ACCM Research Day is an exceptional forum to share insights and innovative research from the past year. Gathering the brilliant minds of the Johns Hopkins ACCM family in one location catalyzes creative thinking, fosters collaboration, and fuels innovation. Together, we aim to fulfill the ACCM mission of becoming a global leader in discovery, innovation, education, and professional development.

Download the 2025 ACCM Research Day Abstract Book which includes the full schedule and abstracts showcasing over 130 presentations across a variety of categories, including AI & Informatics, Pain & Regional Anesthesia, Quality Improvement, and more.

This is our 27th Annual Research Day and this year’s theme is “Genomics and Personalized Medicine in Anesthesiology and Critical Care”. We are looking forward to showcasing all of the amazing research happening in our department.

We encourage participants at all levels of their learning journey to share in the rich resources of the ACCM community, engage in multidisciplinary projects, initiate research collaborations, and seek out mentorship in the department. The scientific program will be organized in different sessions, providing the latest updates and showcasing the most promising research in the field of anesthesiology and critical care medicine. Our research will be presented in the categories: Basic Science: Cardiovascular & Pulmonary; Basic Neuroscience; Clinical Research; Critical Care; Informatics, AI, Engineering, & Technology; Pain & Regional Anesthesiology; and Quality Improvement & Health Systems/Services.

“Integrative Extracellular Vesicle Transcriptomics: Towards a Liquid Biopsy for Chronic Diseases”

Presented by Visiting Professor and Keynote Speaker

Saumya Das, MD, PhD

Professor of Medicine at Harvard Medical School
Faculty member of the Cardiac Arrhythmia Service
Co-Director of the Inherited Arrhythmia Service at Massachusetts General Hospital
As director of Resynchronization and Advanced Cardiac Therapeutics Program, Dr. Das conducts research focused on the discovery and identification of RNA biomarkers in plasma that may prognosticate outcomes related to heart failure and arrhythmic events. A Mass General and Brigham and Women’s research team, led by Dr. Das, is currently validating a newly discovered set of RNA markers in over 4,000 patients as a part of a large-scale, NIH-funded study. Dr. Das hopes one day, certain sets of RNA markers might translate in the clinic as a test to help stratify patients based on risk for earlier and more definitive intervention.
Dr. Das has been the lead PI of several National Center for Advanced Translation (NCAT) grants to discover and validate RNA biomarkers of heart remodeling in heart failure. As part of the NIH Extracellular RNA Communication Consortium he has served as a co-chair of the steering committee. He was inducted in the American Society of Clinical Investigation in 2020 and also received an NIH EIA award (R35). He has served as a principal investigator on several American Heart Association strategic network grants, and is on the advisory board for American Association of Extracellular Vesicles. Work done in his laboratory has led to several patents. He is a cofounder of Long QT Therapeutics and Switch Therapeutics based on research done in his laboratory that seek to advance novel therapies for inherited arrhythmia syndromes and cardiac hypertrophy.

ACCM Research Day 2025 Faculty Hosts

Samarjit Das, PhD
Assistant Professor
Anesthesiology and Critical Care Medicine
Johns Hopkins University School of Medicine

Joseph Walpole, MD, PhD
Assistant Professor
Division of Cardiac Anesthesia
Anesthesiology and Critical Care Medicine
Johns Hopkins University School of Medicine